| 1 |
A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor
Stephen M. Stahl, James F. Pradko, Barbara R. Haight et al. · The Primary Care Companion For CNS Disorders
Open access |
13 Aug 2004 |
497 |
| 2 |
The other face of depression, reduced positive affect: the role of catecholamines in causation and cure
David Nutt, Koen Demyttenaere, Zoltán Janka et al. · Journal of Psychopharmacology
|
18 Oct 2006 |
373 |
| 3 |
The many faces of fatigue in major depressive disorder
Koen Demyttenaere, Jürgen De Fruyt, Stephen M. Stahl · The International Journal of Neuropsychopharmacology
Open access |
Mar 2005 |
289 |
| 4 |
Serotonergic Drugs for Depression and Beyond
Stephen M. Stahl, Clara Lee-Zimmerman, Sylvia Cartwright et al. · Current Drug Targets
|
Apr 2013 |
272 |
| 5 |
Which comes first: atypical antipsychotic treatment or cardiometabolic risk?
Stephen M. Stahl, Laurence Mignon, Jonathan M. Meyer · Acta Psychiatrica Scandinavica
Open access |
12 Jan 2009 |
260 |
| 6 |
15 Years of Clinical Experience With Bupropion HCl
Maurizio Fava, Augustus John Rush, Michael E. Thase et al. · The Primary Care Companion For CNS Disorders
Open access |
15 Jun 2005 |
259 |
| 7 |
L-Methylfolate: A Vitamin for Your Monoamines
Stephen M. Stahl · The Journal of Clinical Psychiatry
Open access |
30 Sep 2008 |
238 |
| 8 |
Hypoactive Sexual Desire Disorder
Irwin Goldstein, Noel N. Kim, Anita H. Clayton et al. · Mayo Clinic Proceedings
Open access |
Dec 2016 |
231 |
| 9 |
Cariprazine as a treatment across the bipolar I spectrum from depression to mania: mechanism of action and review of clinical data
Stephen M. Stahl, Sarah A. Laredo, Debbi Ann Morrissette · Therapeutic Advances in Psychopharmacology
Open access |
2020 |
224 |
| 10 |
Anticonvulsants as Anxiolytics, Part 2: Pregabalin and Gabapentin as α2δ Ligands at Voltage-Gated Calcium Channels
Stephen M. Stahl · The Journal of Clinical Psychiatry
Open access |
15 Apr 2004 |
204 |
| 11 |
Brain circuits determine destiny in depression: a novel approach to the psychopharmacology of wakefulness, fatigue, and executive dysfunction in major depressive disorder.
Stephen M. Stahl, Lishu Zhang, Cristina Damatarca et al. · PubMed
|
2003 |
203 |
| 12 |
Anticonvulsants and the Relief of Chronic Pain: Pregabalin and Gabapentin as α2δ Ligands at Voltage-Gated Calcium Channels
Stephen M. Stahl · The Journal of Clinical Psychiatry
|
15 May 2004 |
201 |
| 13 |
A Critical Review of Atypical Antipsychotic Utilization: Comparing Monotherapy with Polypharmacy and Augmentation
Stephen M. Stahl, M.J.W. Grady · Current Medicinal Chemistry
|
Feb 2004 |
186 |
| 14 |
Neurotransmission of cognition, part 3. Mechanism of action of selective NRIs: both dopamine and norepinephrine increase in prefrontal cortex.
Stephen M. Stahl · PubMed
|
Mar 2003 |
180 |
| 15 |
Anticonvulsants as Anxiolytics, Part 1: Tiagabine and Other Anticonvulsants With Actions on GABA
Stephen M. Stahl · The Journal of Clinical Psychiatry
Open access |
15 Mar 2004 |
178 |
| 16 |
Psychopharmacology of Anticonvulsants: Do All Anticonvulsants Have the Same Mechanism of Action?
Stephen M. Stahl · The Journal of Clinical Psychiatry
Open access |
15 Feb 2004 |
174 |
| 17 |
The Psychopharmacology of Energy and Fatigue
Stephen M. Stahl · The Journal of Clinical Psychiatry
Open access |
15 Jan 2002 |
158 |
| 18 |
Guidelines for the recognition and management of mixed depression
Stephen M. Stahl, Debbi Ann Morrissette, Gianni L. Faedda et al. · CNS Spectrums
Open access |
28 Feb 2017 |
152 |
| 19 |
What Was the Set of Ubiquitin and Ubiquitin-Like Conjugating Enzymes in the Eukaryote Common Ancestor?
Caroline Michelle, Patrick Vourc’h, Laurence Mignon et al. · Journal of Molecular Evolution
Open access |
18 May 2009 |
151 |
| 20 |
Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression
Stephen M. Stahl, Richard Entsuah, Richard L. Rudolph · Biological Psychiatry
|
Dec 2002 |
149 |
| 21 |
"Dopamine System Stabilizers, Aripiprazole, and the Next Generation of Antipsychotics, Part 1: "Goldilocks" Actions at Dopamine Receptors
Stephen M. Stahl · The Journal of Clinical Psychiatry
Open access |
15 Nov 2001 |
145 |
| 22 |
Is Psychopharmacologic "Inoculation" Effective in Preventing Posttraumatic Stress Disorder?
Stephen M. Stahl · The Journal of Clinical Psychiatry
|
15 Jan 2005 |
140 |
| 23 |
Escitalopram in the Treatment of Panic Disorder
Stephen M. Stahl, Ivan P. Gergel, Dayong Li · The Journal of Clinical Psychiatry
|
15 Nov 2003 |
140 |
| 24 |
Dopamine System Stabilizers, Aripiprazole, and the Next Generation of Antipsychotics, Part 2: Illustrating Their Mechanism of Action
Stephen M. Stahl · The Journal of Clinical Psychiatry
Open access |
15 Dec 2001 |
136 |
| 25 |
Understanding pain in depression
Stephen M. Stahl, Mike Briley · Human Psychopharmacology Clinical and Experimental
|
20 Sep 2004 |
128 |
| 26 |
Does Depression Hurt?
Stephen M. Stahl · The Journal of Clinical Psychiatry
Open access |
15 Apr 2002 |
105 |
| 27 |
The relevance of COVID ‐19 pandemic to psychiatry
Donatella Marazziti, Stephen M. Stahl · World Psychiatry
Open access |
11 May 2020 |
104 |
| 28 |
Atypical Antipsychotics: Matching Receptor Profile to Individual Patient's Clinical Profile
Darius K. Shayegan, Stephen M. Stahl · CNS Spectrums
|
Oct 2004 |
94 |
| 29 |
A Phase III, Randomized, Placebo-controlled Trial to Assess the Efficacy and Safety of Once-daily SPN-812 (Viloxazine Extended-release) in the Treatment of Attention-deficit/Hyperactivity Disorder in School-age Children
Azmi F. Nasser, Tesfaye Liranso, Toyin Adewole et al. · Clinical Therapeutics
Open access |
25 Jul 2020 |
85 |
| 30 |
Major Depressive Disorder: Understanding the Significance of Residual Symptoms and Balancing Efficacy with Tolerability
Larry Culpepper, Philip R. Muskin, Stephen M. Stahl · The American Journal of Medicine
Open access |
30 Aug 2015 |
82 |
| 31 |
“Meta-guidelines” for the management of patients with schizophrenia
Stephen M. Stahl, Debbi Ann Morrissette, Leslie Citrome et al. · CNS Spectrums
|
16 Apr 2013 |
75 |
| 32 |
Antipsychotic Polypharmacy: Squandering Precious Resources?
Stephen M. Stahl · The Journal of Clinical Psychiatry
Open access |
15 Feb 2002 |
75 |
| 33 |
Hippocampal nitric oxide upregulation precedes memory loss and Aβ1-40accumulation after chronic brain hypoperfusion in rats
J. C. de la Torre, Bruce A. Pappas, Vincent Prévot et al. · Neurological Research
|
Sep 2003 |
70 |
| 34 |
Clinical outcomes following one-, two-, three-, and four-level anterior cervical discectomy and fusion: a national database study
Peter Y. Joo, Justin R. Zhu, Alexander J. Kammien et al. · The Spine Journal
|
10 Nov 2021 |
68 |
| 35 |
Modulating the serotonin system in the treatment of major depressive disorder
Debbi Ann Morrissette, Stephen M. Stahl · CNS Spectrums
|
Dec 2014 |
68 |
| 36 |
Comparing rates of early pedicle screw loosening in posterolateral lumbar fusion with and without transforaminal lumbar interbody fusion
David H. Kim, Raymond W. Hwang, Gyu-Ho Lee et al. · The Spine Journal
|
5 May 2020 |
66 |
| 37 |
Serum Phosphatidylethanolamine and Lysophosphatidylethanolamine Levels Differentiate Alzheimer’s Disease from Controls and Predict Progression from Mild Cognitive Impairment
Daniel A. Llano, for the Alzheimer’s Disease Neuroimaging Initiative, Viswanath Devanarayan · Journal of Alzheimer s Disease
|
26 Jan 2021 |
65 |
| 38 |
Mechanism of Action of α2δ Ligands: Voltage Sensitive Calcium Channel (VSCC) Modulators
Stephen M. Stahl · The Journal of Clinical Psychiatry
|
15 Aug 2004 |
64 |
| 39 |
Does hearing loss lead to dementia? A review of the literature
Yosra Nadhimi, Daniel A. Llano · Hearing Research
Open access |
30 Jul 2020 |
62 |
| 40 |
Fibromyalgia—pathways and neurotransmitters
Stephen M. Stahl · Human Psychopharmacology Clinical and Experimental
|
28 May 2009 |
60 |
| 41 |
The Psychopharmacology of Painful Physical Symptoms in Depression
Stephen M. Stahl · The Journal of Clinical Psychiatry
|
15 May 2002 |
60 |
| 42 |
A Temperature-sensitive Mutation of Crygs in the Murine Opj Cataract
Debasish Sinha, M. Keith Wyatt, Robert Sarra et al. · Journal of Biological Chemistry
Open access |
Mar 2001 |
58 |
| 43 |
Once-Daily SPN-812 200 and 400 mg in the treatment of ADHD in School-aged Children: A Phase III Randomized, Controlled Trial
Azmi F. Nasser, Tesfaye Liranso, Toyin Adewole et al. · Clinical Therapeutics
Open access |
6 Mar 2021 |
55 |
| 44 |
TRPV1 Antagonists and Chronic Pain: Beyond Thermal Perception
Michael R. Brandt, Chad E. Beyer, Stephen M. Stahl · Pharmaceuticals
Open access |
2 Feb 2012 |
55 |
| 45 |
High-Cost Use of Second-Generation Antipsychotics Under California's Medicaid Program
Stephen M. Stahl, Meghan M. Grady · Psychiatric Services
|
2006 |
54 |
| 46 |
Differences in mechanism of action between current and future antidepressants.
Stephen M. Stahl, Meghan M. Grady · PubMed
|
2003 |
54 |
| 47 |
Antidepressant Treatment of Psychotic Major Depression: Potential Role of the σ Receptor
Stephen M. Stahl · CNS Spectrums
|
Apr 2005 |
53 |
| 48 |
Practical guide for prescribing MAOIs: debunking myths and removing barriers
Meghan M. Grady, Stephen M. Stahl · CNS Spectrums
|
26 Apr 2012 |
53 |
| 49 |
Anticonvulsants as Mood Stabilizers and Adjuncts to Antipsychotics: Valproate, Lamotrigine, Carbamazepine, Oxcarbazepine and Actions at Voltage-Gated Sodium Channels
Stephen M. Stahl · The Journal of Clinical Psychiatry
Open access |
15 Jun 2004 |
52 |
| 50 |
Neurotransmission of Cognition, Part 2: Selective NRIs Are Smart Drugs: Exploiting Regionally Selective Actionson Both Dopamine and Norepinephrineto Enhance Cognition
Stephen M. Stahl · The Journal of Clinical Psychiatry
Open access |
15 Feb 2003 |
49 |